Clinical Trial Update: Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a demethylated drug for nasopharyngeal carcinoma; current status is unknown in the provided source.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Demethylated Drug

Snippet

Sponsor: Wei Jiang | Conditions: Nasopharyngeal Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN